MATTHEW SCHOLL
GALVESTON, TX NPI 1215677232
Browse related groups: TX GENZYME CORPORATION All categories
General Payments — all program years on this page
$903.06
- Category: General Payments
- Program years: PY2023–2024
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $706.14 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $706.14 | 6 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $222.16 | 2 |
| ABBVIE INC. | $125.61 | 1 |
| E.R. Squibb & Sons, L.L.C. | $121.75 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $120.97 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $115.65 | 1 |
By program year
Records — PY2024 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1087335941 | Novartis Pharmaceuticals Corporation | $120.97 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101387822 | E.R. Squibb & Sons, L.L.C. | $121.75 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106039900 | ABBVIE INC. | $125.61 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117919745 | Boehringer Ingelheim Pharmaceuticals, Inc. | $115.65 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139966257 | GENZYME CORPORATION | $137.96 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139966277 | GENZYME CORPORATION | $84.20 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.